Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Agomelatine as a Novel Treatment Option in Panic Disorder, Results From an 8-Week Open-Label Trial

Huijbregts, Klaas M. PhD; Batelaan, Neeltje M. MD, PhD; Schonenberg, Judy BSc; Veen, Gerthe MD, PhD; van Balkom, Anton J. MD, PhD

Journal of Clinical Psychopharmacology: June 2015 - Volume 35 - Issue 3 - p 336–338
doi: 10.1097/JCP.0000000000000313
Letters to the Editors — Research Reports
Buy

Department of Psychiatry VU University Medical Centre and Department of Anxiety and Depression GGZ inGeest Amsterdam, The Netherlands khuijbregts@gmail.com

Department of Psychiatry VU University Medical Centre Department of Anxiety and Depression GGZ inGeest and EMGO Institute for Health and Care Research (EMGO+) Amsterdam, The Netherlands

Department of Psychiatry VU University Medical Centre, and GGZ inGeest Amsterdam, The Netherlands

Department of Psychiatry VU University Medical Centre and Department of Anxiety and Depression GGZ inGeest Amsterdam, The Netherlands

Department of Psychiatry VU University Medical Centre Department of Anxiety and Depression GGZ inGeest and EMGO Institute for Health and Care Research (EMGO+) Amsterdam, The Netherlands

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.